Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.45
+0.06 (0.72%)
At close: Jul 6, 2026, 4:00 PM EDT
8.60
+0.15 (1.78%)
After-hours: Jul 6, 2026, 7:58 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $545.2 million as of July 6, 2026. Its market cap has decreased by -0.01% in one year.
Market Cap
545.20M
Enterprise Value
-61.30M
1-Year Change
-0.01%
Ranking
Category
Stock Price
$8.45
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $545.20M, an increase of 5.63%. That is a compound annual growth rate of 0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 545.20M | -28.42% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 567.88M |
| Contineum Therapeutics | 564.53M |
| Editas Medicine | 560.14M |
| Neurogene | 558.44M |
| Assembly Biosciences | 549.73M |
| Shattuck Labs | 540.60M |
| Kyverna Therapeutics | 540.47M |
| XOMA Royalty | 539.26M |